Follow Chr. Hansen A/S

Changes to the Board of Directors of Chr. Hansen Holding A/S

Press release   •   Mar 17, 2010 14:00 UTC

On March 16, Henrik Poulsen and Alice Dautry were appointed new members of the Board of Chr. Hansen Holding A/S. At the same time Lennart Holm, PAI partners, stepped down.

In order to further strengthen the company, Chr. Hansen Holding A/S has named two new members to its board of directors:


Henrik Poulsen [born 1967] has served as the Chief Executive Officer (CEO) of TDC A/S since November 2008 and holds a M.Sc. in Finance and Accounting from Aarhus School of Business. He has had significant experience in strategic planning and execution as a result of senior positions in companies such as McKinsey & Co., LEGO A/S and KKR Capstone, and these capabilities will prove valuable to the board.
Alice Dautry [born 1950] has served as President of the Institut Pasteur a world leading research institute in microbiology since 2005 and has a strong scientific profile within immune health and microbiology. Prof. Dautry trained as a solid state physicist at the University of Paris and as a molecular biologist at the University of New York at Stony Brook and the National Institutes of Health in Maryland. Alice Dautry will bring a strong scientific background in the field of Health and Nutrition to the board.


The present Chr. Hansen Board of Directors consists of: Ole Andersen (chairman), Frédéric Stévenin (vice-chairman), Alice Dautry, Gaëlle d’Engremont, Malene Lunddal Hansen, Svend Laulund, Henrik Poulsen, Martin Seidel and Lionel Zinsou.

For further information on this release, please contact:

Ole Andersen, Chairman
Tel.: +45 4574 7623

Kristine Ahrensbach, Corporate Communications
Tel.: +45 2249 5115

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Comments (0)

Add comment

Comment

By submitting the comment you agree that your personal data will be processed according to Mynewsdesk's Privacy Policy.